Anixa Biosciences Secures Australian Patent for Breast Cancer Vaccine
Anixa Biosciences receives an Australian patent for its breast cancer vaccine technology, expanding its global intellectual property portfolio.
Breast Cancer Prevention | 22/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy